News
US Stock Market on March 12: The Dow Jones Industrial Average, the S&P 500 and the Nasdaq Composite indices eked out mild gains amid choppy trade on Wednesday, in some respite for Wall Street bulls ...
ADAR1 Capital Management LLC dramatically boosted its holdings in Regeneron Pharmaceuticals by 56.3% during Q4, grabbing 1,361 shares worth nearly $969,000. Several other institutional investors also ...
Fmr LLC gave Regeneron the cold shoulder, trimming its stake by 20.9% and dropping 2.16 million shares in Q4. This move ...
StockStory.org on MSN4d
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results